Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 12, 2016

Primary Completion Date

August 23, 2017

Study Completion Date

September 13, 2017

Conditions
Glioblastoma
Interventions
DRUG

Chlorogenic acid

Chlorogenic acid for injection is polyphenols, micromolecular and un-endogenous substance. It might play the role of cancer treatment via balancing tumor micro-environmental immune status according to the stability and rationality of immunodeficiency and endogenous immune material expression around the tumor. Chlorogenic acid for injection is made from chlorogenic acid (purity≥98%) which is extracted from folium cortex eucommiae.Chlorogenic acid and its preparations have not been reported as chemical drug and marketed around the world.

Trial Locations (1)

100038

Beijing Shijitan Hospital,Capital Medical University, Beijing

All Listed Sponsors
collaborator

Beijing Shijitan Hospital, Capital Medical University

OTHER

lead

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

INDUSTRY

NCT02728349 - Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma | Biotech Hunter | Biotech Hunter